Tenax Therapeutics (TENX) Net Income (2010 - 2026)
Tenax Therapeutics (TENX) posted quarterly Net Income of -$76.4 million for Q2 2026, down 604.8% year-over-year from $15.1 million in Q2 2025, and up 10.77% on a QoQ basis from -$85.6 million in Q1 2026.
Tenax Therapeutics (TENX) Net Income (2010 - 2026) Analysis & Trends
Tenax Therapeutics has reported Net Income for 16 years, with the latest figure at -$76.4 million in Q2 2026.
- Net Income for Q2 2026 came in at -$76.4 million, down 604.8% year-over-year; the trailing twelve-month figure through Jun 2026 was -$204.3 million (down 549.17% YoY), and the FY2025 annual result was -$102.9 million, down 73.66% from the prior year.
- Net Income climbed to -$76.4 million in Q2 2026, from -$85.6 million in the prior quarter.
- Over five years, Net Income peaked at $2.7 million in Q3 2022 and troughed at -$85.6 million in Q1 2026.
- A 5-year average of -$13.9 million and a median of -$3.9 million in 2024 frame the typical range for Net Income.
- The widest annual swing landed in 2022, when Net Income jumped 104.1%; it then plunged 722.52% in 2026.
- A 5-year view of Net Income shows it stood at $2.6 million in 2022, then sank by 580.63% to -$12.3 million in 2023, then jumped by 48.96% to -$6.3 million in 2024, then sank by 147.82% to -$15.5 million in 2025, then sank by 391.92% to -$76.4 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$76.4 million in Q2 2026, -$85.6 million in Q1 2026, and -$15.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | -17.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -76.40 Mn |
| Mar 31, 2026 | -85.62 Mn |
| Dec 31, 2025 | -15.53 Mn |
| Sep 30, 2025 | -26.79 Mn |
| Jun 30, 2025 | -10.84 Mn |
| Mar 31, 2025 | -10.41 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Jun 30, 2024 | -3.58 Mn |
| Mar 31, 2024 | -3.80 Mn |
| Dec 31, 2023 | -12.28 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | -1.11 Mn |
| Mar 31, 2023 | -1.41 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 2.69 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | -2.72 Mn |
| Dec 31, 2021 | -62.24 Mn |
| Sep 30, 2021 | 3.45 Mn |